...
机译:Toll样受体2参与CD4 + sup> T细胞促进结核性胸膜炎患者的局部免疫反应
1 Shenzhen Clinical Research Center for Infectious Diseases, Shenzhen Third Hospital, Shenzhen 2 Shenzhen-Hong Kong Institute of Infectious Diseases, Affiliated Shenzhen Third Hospital, Guangdong Medical College, Shenzhen 3 Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing, China 4 Department of Pediatrics and Immunobiology, BIO5 Institute and Arizona Cancer Center, University of Arizona, Tucson 5 Department of Neurosurgery, University of Colorado Health Science Center, Aurora;
机译:在CD4(+)T细胞上参与Toll样受体2有助于结核性胸膜炎患者的局部免疫反应。
机译:结核性胸膜炎中ESAT-6和CFP-10-特异的Th1,Th22和Th17细胞可能有助于抵抗结核分枝杆菌感染的局部免疫反应。
机译:通过自然产生表达Toll样受体的CD4 +调节性T细胞来控制免疫反应。
机译:Sarcopters scabiei var.caprae诱导兔免疫应答和roll样受体-2(tlr-2)作为标记的蛋白质
机译:Toll样受体配体激活的树突状细胞对人CD4 + T细胞反应的影响。
机译:通过自然产生表达Toll样受体的CD4 +调节性T细胞来控制免疫反应。
机译:Toll样受体2对CD4 + T细胞的接合有助于结核性胸膜患者的局部免疫反应